Patent intelligence · CN
CN 116783219
T cell recruitment polypeptides based on TCR alpha/beta reactivity
T cell recruitment polypeptides based on TCR alpha/beta reactivity
Patent details — CN 116783219
- Jurisdiction
- CN
- Status
- granted
- Grant date
- Sep 19, 2023
- Expiration
- Sep 14, 2043
- Applicant
- ABLYNX NV
- CPC classes
- A61P/3502
Quick answer
CN 116783219 (T cell recruitment polypeptides based on TCR alpha/beta reactivity) is held by ABLYNX NV. Status: granted. Granted Sep 19, 2023. Expires Sep 14, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ABLYNX NV
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P/3502
More from ABLYNX NV
Related pharmaceutical patents in our USPTO index.
-
WO 2026078159
AGENTS D'ACTIVATION DE CELLULES IMMUNITAIRES ET PROCÉDÉS LES COMPRENANT
granted -
WO 2026030375
NANOPARTICULES LIPIDIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
granted -
WO 2025262150
MOLÉCULES DE RECRUTEMENT D'ANTICORPS
granted -
AR 133055
DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA DIRIGIDOS A PD-L1
granted -
MX 2025007399
PROTEIN-BASED CONJUGATION CARRIERS
granted -
WO 2025133166
VÉHICULES À BASE DE PROTÉINES POUR CONJUGAISON D'AMINE SPÉCIFIQUE À UN SITE
granted -
WO 2025133252
DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT CEACAM5
granted -
WO 2025133253
EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE
granted
Frequently asked questions
What is US patent 116783219?
CN 116783219 (T cell recruitment polypeptides based on TCR alpha/beta reactivity) is held by ABLYNX NV. Status: granted. Granted Sep 19, 2023. Expires Sep 14, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CN 116783219?
ABLYNX NV is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CN 116783219 expire?
Our index shows an expiration date of Sep 14, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.